These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24112388)
21. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress. Poschmann G; Grzendowski M; Stefanski A; Bruns E; Meyer HE; Stühler K Biochim Biophys Acta; 2015 Jun; 1854(6):624-31. PubMed ID: 25484280 [TBL] [Abstract][Full Text] [Related]
22. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949 [TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells. Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292 [TBL] [Abstract][Full Text] [Related]
24. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes. Harada K; Ferdous T; Ueyama Y Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635 [TBL] [Abstract][Full Text] [Related]
25. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea. Hank NC; Shapiro JR; Scheck AC BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339 [TBL] [Abstract][Full Text] [Related]
26. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
27. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway. Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208 [TBL] [Abstract][Full Text] [Related]
28. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
29. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling. Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010 [TBL] [Abstract][Full Text] [Related]
30. Altered nuclear localization of bax protein in BCNU-resistant glioma cells. Joy A; Panicker S; Shapiro JR J Neurooncol; 2000 Sep; 49(2):117-29. PubMed ID: 11206007 [TBL] [Abstract][Full Text] [Related]
31. Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione. Yang DI; Yin JH; Ju TC; Chen LS; Hsu CY Free Radic Biol Med; 2004 May; 36(10):1317-28. PubMed ID: 15110396 [TBL] [Abstract][Full Text] [Related]
32. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas. Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135 [TBL] [Abstract][Full Text] [Related]
33. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model. Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080 [TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype. Cervantes-Arias A; Pang LY; Argyle DJ Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947 [TBL] [Abstract][Full Text] [Related]
35. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer. Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665 [TBL] [Abstract][Full Text] [Related]
36. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells. Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells. Sukumari-Ramesh S; Prasad N; Alleyne CH; Vender JR; Dhandapani KM BMC Cancer; 2015 Mar; 15():118. PubMed ID: 25851054 [TBL] [Abstract][Full Text] [Related]
38. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial. Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S; J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262 [TBL] [Abstract][Full Text] [Related]
39. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755 [TBL] [Abstract][Full Text] [Related]
40. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell. Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]